First test of ENC0653 ointment in healthy adults
Treatments studied
This study tests a new ointment called ENC0653 in healthy adults to see if it is safe and how it works in the body. It is the first time this ointment is being tested in people, so if you are healthy and your skin is clear, you may be able to help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You are in good general health with no active skin issues like rashes, sores, or tattoos on the area where the ointment is applied.
- You have no history of blood clots, cancer, or serious immune system diseases.
- You are not pregnant, breastfeeding, or planning to become pregnant, and you agree to use birth control during the study.
- You have not had a major surgery or taken part in another drug trial within the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This trial tests a new ointment called CU-10101. It will first be tested in healthy volunteers to check safety, and then in people with atopic dermatitis (eczema) to see how well it works for mild to moderate symptoms.
This study tests a new ointment (HL-300) designed to treat mild-to-moderate atopic dermatitis (a chronic skin condition causing itching and inflammation). You would apply it to affected skin areas to see if it safely reduces symptoms.
This early-stage study tests a new ointment (YR001) on healthy volunteers to see how it is absorbed through the skin and how safe it is. It helps researchers understand how the ointment behaves in the body before it is tested in people with skin conditions.
This study tests a new ointment called IN-115314 for adults with mild to moderate eczema. Researchers want to see if it helps control symptoms like itching and redness better than a placebo, and check that it's safe to use.
This trial tests a new topical medication for eczema, a chronic itchy skin condition. The goal is to see if it improves symptoms and is safe for people with mild to moderate eczema affecting a limited body area.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.